Portugal INFARMED

Enhertu (trastuzumab deruxtecano) – Public funding assessment report available; approval of preliminary assessment requests

Original title: Enhertu (Trastuzumab deruxtecano) | Relatórios de avaliação de financiamento público disponível na Infomed | Deferimento dos pedidos de avaliação prévia

Public funding assessment report for Enhertu (trastuzumab deruxtecano) published; preliminary assessment requests approved.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement Portugal PharmaceuticalsReimbursement

Data : 11/08/2026

Read the official source ↗

Published by Portugal INFARMED. HealthSignal links to the original document; the summary above is extracted from the source text.